Shareholders Shouldn’t Be Too Comfortable With INFINITT Healthcare's (KOSDAQ:071200) Strong Earnings
May 22
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthtech Industry Analysis
UpdatedJul 03, 2025
DataAggregated Company Financials
Companies12
- 7D-5.2%
- 3M9.0%
- 1Y5.0%
- YTDn/a
Over the last 7 days, the Healthtech industry has dropped 5.2%, driven by Lunit declining 5.7%. This takes the industry's 12 month performance to a gain of 5.0%. As for the next few years, earnings are expected to grow by 46% per annum.
Industry Valuation and Performance
Has the South Korean Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 06 Jul 2025 | ₩3.2t | ₩581.6b | -₩119,895,420,550.00 | 25.3x | -26.6x | 5.5x |
| Tue, 03 Jun 2025 | ₩3.0t | ₩583.2b | -₩118,503,378,990.00 | 22.9x | -25x | 5.1x |
| Thu, 01 May 2025 | ₩3.1t | ₩563.2b | -₩137,189,191,030.00 | 10.7x | -22.7x | 5.5x |
| Sat, 29 Mar 2025 | ₩3.0t | ₩563.2b | -₩146,353,499,290.00 | 9.3x | -20.4x | 5.3x |
| Mon, 24 Feb 2025 | ₩3.3t | ₩538.4b | -₩84,534,143,370.00 | 11x | -39x | 6.1x |
| Wed, 22 Jan 2025 | ₩3.2t | ₩536.1b | -₩85,171,350,030.00 | 10.9x | -37.5x | 6x |
| Fri, 20 Dec 2024 | ₩3.3t | ₩536.1b | -₩85,171,350,030.00 | 11.4x | -39.1x | 6.2x |
| Sun, 17 Nov 2024 | ₩2.5t | ₩513.2b | -₩83,016,859,320.00 | 12.3x | -30.3x | 4.9x |
| Tue, 15 Oct 2024 | ₩2.4t | ₩504.1b | -₩85,882,642,230.00 | 13.2x | -28.5x | 4.9x |
| Thu, 12 Sep 2024 | ₩2.4t | ₩504.1b | -₩85,882,642,230.00 | 13x | -28.1x | 4.8x |
| Sat, 10 Aug 2024 | ₩2.3t | ₩479.3b | -₩114,966,911,080.00 | 16.5x | -19.6x | 4.7x |
| Mon, 08 Jul 2024 | ₩2.7t | ₩479.3b | -₩114,966,911,080.00 | 17.2x | -23.7x | 5.7x |
| Wed, 05 Jun 2024 | ₩3.1t | ₩480.1b | -₩121,015,467,340.00 | 11.7x | -25.8x | 6.5x |
| Fri, 03 May 2024 | ₩3.1t | ₩472.9b | -₩116,225,868,680.00 | 12.1x | -26.8x | 6.6x |
| Sun, 31 Mar 2024 | ₩3.4t | ₩472.9b | -₩116,225,868,680.00 | 12.6x | -28.9x | 7.1x |
| Tue, 27 Feb 2024 | ₩3.8t | ₩466.9b | -₩121,958,864,840.00 | 17.4x | -31.5x | 8.2x |
| Thu, 25 Jan 2024 | ₩4.0t | ₩470.3b | -₩126,434,108,550.00 | 15.3x | -31.4x | 8.4x |
| Sat, 23 Dec 2023 | ₩4.4t | ₩473.1b | -₩129,782,846,150.00 | 14.1x | -33.6x | 9.2x |
| Mon, 20 Nov 2023 | ₩4.2t | ₩473.0b | -₩129,648,870,530.00 | 15.9x | -32.2x | 8.8x |
| Wed, 18 Oct 2023 | ₩3.7t | ₩472.1b | -₩129,827,783,480.00 | 15.8x | -28.6x | 7.9x |
| Fri, 15 Sep 2023 | ₩4.8t | ₩468.0b | -₩119,615,334,030.00 | 17.8x | -40.4x | 10.3x |
| Sun, 13 Aug 2023 | ₩4.0t | ₩460.8b | -₩96,255,067,860.00 | 18x | -41.3x | 8.6x |
| Tue, 11 Jul 2023 | ₩3.6t | ₩460.8b | -₩96,255,067,860.00 | 18x | -37.4x | 7.8x |
| Thu, 08 Jun 2023 | ₩2.9t | ₩470.4b | -₩94,103,710,740.00 | 18.5x | -30.8x | 6.2x |
| Sat, 06 May 2023 | ₩2.1t | ₩454.8b | -₩121,205,489,640.00 | 83.3x | -17x | 4.5x |
| Mon, 03 Apr 2023 | ₩1.9t | ₩454.8b | -₩121,205,489,640.00 | 89.1x | -15.4x | 4.1x |
| Wed, 01 Mar 2023 | ₩2.1t | ₩446.2b | -₩100,021,271,520.00 | 25.1x | -21.1x | 4.7x |
| Fri, 27 Jan 2023 | ₩1.9t | ₩448.5b | -₩95,899,607,010.00 | 26.4x | -19.9x | 4.3x |
| Sun, 25 Dec 2022 | ₩1.5t | ₩448.5b | -₩95,899,607,010.00 | 22.4x | -15.8x | 3.4x |
| Tue, 22 Nov 2022 | ₩1.5t | ₩443.0b | -₩87,899,877,380.00 | 19.6x | -17.3x | 3.4x |
| Thu, 20 Oct 2022 | ₩1.1t | ₩437.6b | -₩42,477,231,270.00 | 19.9x | -26.9x | 2.6x |
| Sat, 17 Sep 2022 | ₩1.2t | ₩437.6b | -₩42,477,231,270.00 | 21x | -29.3x | 2.8x |
| Mon, 15 Aug 2022 | ₩1.5t | ₩433.8b | -₩36,565,870,330.00 | 24.8x | -39.7x | 3.3x |
| Wed, 13 Jul 2022 | ₩1.3t | ₩433.8b | -₩36,565,870,330.00 | 24.4x | -36.8x | 3.1x |
Price to Earnings Ratio
-36.8x
Current Industry PE
- Investors are relatively neutral on the South Korean Health Care Technology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
- The earnings for companies in the Health Care Technology industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 10% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does South Korean Healthtech compare with similar industries?
| KR Market | -0.065% | |
| Healthcare | 2.69% | |
| Healthtech | -5.20% | |
| Healthtech | -5.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A311690 CJ Bioscience | ₩9.51k | 2.5% +₩3.0b | -22.9% | PS36.8x | |
| A263700 CarelabsLtd | ₩3.54k | 1.7% +₩1.2b | -0.7% | PE26x |